Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA) [Phase 2]
Phase 2 trial update on Gallium-68 HA-DOTATATE PET/CT imaging for Giant Cell Arteritis has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: KPL-301 for Subjects With Giant Cell Arteritis [Phase 2]
Phase 2 clinical trial update for KPL-301 in giant cell arteritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis [Phase 2]
Phase 2 trial evaluating safety and efficacy of secukinumab in Giant Cell Arteritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Tocilizumab Plus a Short Prednisone Taper for GCA [Phase 4]
A Phase 4 trial evaluating tocilizumab with a short prednisone taper for giant cell arteritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Baricitinib in Relapsing Giant Cell Arteritis [Phase 2]
Phase 2 trial update for baricitinib in relapsing giant cell arteritis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA [Phase 2]
Phase 2 clinical trial evaluating tocilizumab for acute anterior ischemic optic neuropathy related to giant cell arteritis.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of sarilumab in giant cell arteritis was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA). [Phase 1]
Phase 1 trial update evaluating pharmacokinetics, pharmacodynamics, and safety of Tocilizumab in Giant Cell Arteritis has completed with res…
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab [Phase 1, Phase 2]
Phase 1/2 trial investigating ultra-short glucocorticoids with tocilizumab for giant cell arteritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering [Phase 3]
Phase 3 trial update comparing two standardized corticosteroid tapering regimens for giant cell arteritis; recruitment not yet started.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA) [Phase 3]
An extension study to evaluate the long-term safety of subcutaneous tocilizumab in participants with giant cell arteritis completed.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: Ustekinumab for the Treatment of Giant Cell Arteritis [Phase 1, Phase 2]
Phase 1/2 trial of ustekinumab for Giant Cell Arteritis was terminated, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Assessment of Giant Cell Arteritis Medical Practices in France
A completed clinical trial assessing medical practices for Giant Cell Arteritis in France; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis [Phase 3]
Phase 3 trial of sirukumab in giant cell arteritis was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Tocilizumab for Patients With Giant Cell Arteritis [Phase 2]
Phase 2 trial evaluating tocilizumab for giant cell arteritis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis [Phase 2]
Phase 2 trial evaluating abatacept for adults with Takayasu arteritis and giant cell arteritis completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study. [Phase 2]
Phase 2 proof-of-concept trial evaluating tocilizumab as add-on therapy to corticosteroids in giant cell arteritis (completed).
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission. [Phase 4]
Phase 4 trial update on dose-tapering and interruption of tocilizumab in Giant Cell Arteritis patients who have achieved clinical remission.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety of tocilizumab (RoActemra/Actemra) in Giant Cell Arteritis has completed with results …
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
This clinical trial update reports the completion of a study evaluating carotid artery neovascularization in patients with Takayasu's arteri…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Hydroxychloroquine in Giant Cell Arteritis [Phase 3]
Phase 3 clinical trial evaluating hydroxychloroquine for Giant Cell Arteritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis [Phase 2]
A Phase II randomized study compared glucocorticoids with versus without methotrexate for giant cell arteritis; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis [Phase 3]
Phase 3 trial update evaluating adalimumab (Humira) to spare steroid use in giant cell arteritis; the study has completed.